Abstract
It has been suggested that long term treatment with calcium antagonist drugs might inhibit platelet function and lead to an anti-atheromatous effect. However recent data have also suggested that such an effect might increase mortality due to an increased incidence of gastrointestinal bleeding. We identified 43 subjects from general practice with uncomplicated mild to moderate hypertension to compare the effects of the calcium antagonist isradipine with that of the β-blocker atenolol on platelet function, plasma β-thromboglobulin levels, fibrinolysis, and serum lipids in a randomised double-blind parallel group study. After careful evaluation to exclude concomitant aspirin use, only 24 subjects were eligible to enter the study. While isradipine and atenolol produced comparable and clinically significant falls in blood pressure (167 ± 2 /102 ± 1 to 153 ± 3/91 ± 2 mm Hg, and 165 ± 2/101 ± 1 to 156 ± 4/91 ± 2 mm Hg, respectively), neither drug produced a detectable effect on ex vivo platelet aggregation, platelet retention, or thromboxane generation with adrenaline, collagen, adenosine- di-phosphate, or platelet activating factor. However a decrease in plasma β-thromboglobulin levels was observed which reached statistical significance (P < 0.05) after 12 weeks treatment in the isradipine but not the atenolol group. a 39% reduction with isradipine compared with 34% following atenolol treatment. euglobulin clot lysis time was not altered by either drug. serum cholesterol concentrations were also unaltered by drug treatment. therapeutic doses of the calcium antagonist isradipine may produce a minor indirect effect on platelet function after several weeks of treatment. however, this is of doubtful clinical importance and may simply reflect an effect of lowered blood pressure on platelet function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, A., McPherson, J., Taylor, M. et al. Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects. J Hum Hypertens 11, 783–788 (1997). https://doi.org/10.1038/sj.jhh.1000449
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000449
Keywords
This article is cited by
-
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise
American Journal of Cardiovascular Drugs (2019)
-
Dihydropyridine Calcium Antagonists Increase Fibrinolytic Activity: A Systematic Review
Journal of Cerebral Blood Flow & Metabolism (2007)